Literature DB >> 7958038

Visual field interpretation with a personal computer based neural network.

E Mutlukan1, D Keating.   

Abstract

The Computer Assisted Touch Screen (CATS) and Computer Assisted Moving Eye Campimeter (CAMEC) are personal computer (PC)-based video-campimeters which employ multiple and single static stimuli on a cathode ray tube respectively. Clinical studies show that CATS and CAMEC provide comparable results to more expensive conventional visual field test devices. A neural network has been designed to classify visual field data from PC-based video-campimeters to facilitate diagnostic interpretation of visual field test results by non-experts. A three-layer back propagation network was designed, with 110 units in the input layer (each unit corresponding to a test point on the visual field test grid), a hidden layer of 40 processing units, and an output layer of 27 units (each one corresponding to a particular type of visual field pattern). The network was trained by a training set of 540 simulated visual field test result patterns, including normal, glaucomatous and neuro-ophthalmic defects, for up to 20,000 cycles. The classification accuracy of the network was initially measured with a previously unseen test set of 135 simulated fields and further tested with a genuine test result set of 100 neurological and 200 glaucomatous fields. A classification accuracy of 91-97% with simulated field results and 65-100% with genuine field results were achieved. This suggests that neural networks incorporated into PC-based video-campimeters may enable correct interpretation of results in non-specialist clinics or in the community.

Entities:  

Mesh:

Year:  1994        PMID: 7958038     DOI: 10.1038/eye.1994.65

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  8 in total

1.  Towards the automatic interpretation of retinal images.

Authors:  P Undrill
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

2.  Predicting glaucomatous progression in glaucoma suspect eyes using relevance vector machine classifiers for combined structural and functional measurements.

Authors:  Christopher Bowd; Intae Lee; Michael H Goldbaum; Madhusudhanan Balasubramanian; Felipe A Medeiros; Linda M Zangwill; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-30       Impact factor: 4.799

3.  Baseline visual field findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).

Authors:  John L Keltner; Chris A Johnson; Kimberly E Cello; Michael Wall
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-29       Impact factor: 4.799

4.  Spatial classification of glaucomatous visual field loss.

Authors:  D B Henson; S E Spenceley; D R Bull
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

5.  Automatic detection of diabetic retinopathy using an artificial neural network: a screening tool.

Authors:  G G Gardner; D Keating; T H Williamson; A T Elliott
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

6.  Machine learning classifiers detect subtle field defects in eyes of HIV individuals.

Authors:  Igor Kozak; Pamela A Sample; Jiucang Hao; William R Freeman; Robert N Weinreb; Te-Won Lee; Michael H Goldbaum
Journal:  Trans Am Ophthalmol Soc       Date:  2007

7.  Assessing visual field clustering schemes using machine learning classifiers in standard perimetry.

Authors:  Catherine Boden; Kwokleung Chan; Pamela A Sample; Jiucang Hao; Te-Wan Lee; Linda M Zangwill; Robert N Weinreb; Michael H Goldbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-12       Impact factor: 4.799

8.  Pattern recognition can detect subtle field defects in eyes of HIV individuals without retinitis under HAART.

Authors:  Michael H Goldbaum; Igor Kozak; Jiucang Hao; Pamela A Sample; TeWon Lee; Igor Grant; William R Freeman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-24       Impact factor: 3.117

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.